An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.
Am J Ment Retard
; 95(1): 93-102, 1990 Jul.
Article
en En
| MEDLINE
| ID: mdl-2167107
Several recent reports have indicated that opioid blockers are effective in attenuating self-injurious behavior (SIB). In the present study, four patients with SIB were challenged with four fixed doses (0, 25, 50, 100 mg) of naltrexone. In a double-blind procedure, all patients received each dose on a different week as determined by latin square design. Naltrexone was given on Monday and Wednesday of each week, and patients were videotaped daily for 10 minutes in the morning and afternoon. The tapes were scored for incidents of SIB, stereotypy, and activity, with interrater reliability of 0.93. The Conners Teacher Rating Scale was administered by staff in the morning and afternoon each day. The Vineland was completed each week (Thursday). All patients had decreased SIB when treated with naltrexone. Three patients decreased their SIB as dose of naltrexone increased. There were no consistent effects of naltrexone on stereotypy, activity, or performance on the Conners or the Vineland. These results suggest that endogenous opioids are implicated in SIB and that naltrexone is a powerful tool for examination of this treatment-resistant behavior.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Automutilación
/
Conducta Estereotipada
/
Discapacidad Intelectual
/
Naltrexona
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Am J Ment Retard
Asunto de la revista:
TRANSTORNOS MENTAIS
Año:
1990
Tipo del documento:
Article
Pais de publicación:
Estados Unidos